Common use of Other Investors Clause in Contracts

Other Investors. Except as set forth on Schedule 2.1(s)(i), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(ii), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the Securities.

Other Investors. Except as set forth on Schedule 2.1(s)(i)in Section 2.1(s) of the Disclosure Schedule, there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(iiin SCHEDULE 2.1(s), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrant Shares or the Warrants.

Other Investors. Except as set forth on Schedule 2.1(s)(iSCHEDULE 2.1(q), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(iiin SCHEDULE 2.1(q), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable intoexercisable, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution dilution, preemptive or similar rights that would be affected or triggered by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrant Shares, or the Warrants.

Other Investors. Except as set forth on Schedule 2.1(s)(iSCHEDULE 2.1(S), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(iiin SCHEDULE 2.1(S), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrants or the Warrant Shares.

Other Investors. Except Other than the Securities and except as set forth on Schedule 2.1(s)(i), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except Other than the Securities and except as set forth on Schedule 2.1(s)(ii), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrants or the Warrant Shares.

Other Investors. Except as set forth on Schedule 2.1(s)(i2.1(r), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on in Schedule 2.1(s)(ii2.1(r), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution dilution, preemptive or similar rights that would be affected affecte or triggered by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrant Shares or the Warrants.

Other Investors. Except as set forth on Schedule 2.1(s)(i2.1(t)(i), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(ii2.1(t)(ii), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Options, the Option Shares, the Warrants or the Warrant Shares.

Other Investors. Except as set forth on Schedule 2.1(s)(i2.1(t), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(ii2.1(t), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrants or the Warrant Shares.

Other Investors. Except as set forth on Schedule 2.1(s)(i)2.1, there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on in Schedule 2.1(s)(ii)2.1, there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesNotes or the Common Shares.

Other Investors. Except as set forth on Schedule 2.1(s)(i2.1(r), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on in Schedule 2.1(s)(ii2.1(r), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesPreferred Shares or the Warrants.

Other Investors. Except as set forth on Schedule 2.1(s)(i2.1(s), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on in Schedule 2.1(s)(ii2.1(s), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrants or the Warrant Shares.

Other Investors. Except as set forth on Schedule SCHEDULE 2.1(s)(i), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule SCHEDULE 2.1(s)(ii), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrants or the Warrant Shares.

Other Investors. Except as set forth on Schedule 2.1(s)(i2.1(t), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on in Schedule 2.1(s)(ii2.1(t), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesPreferred Shares.

Other Investors. Except as set forth on Schedule 2.1(s)(iSCHEDULE 2.1(s), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(iiin SCHEDULE 2.1(s), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrants or the Warrant Shares.

Other Investors. Except as set forth on Schedule 2.1(s)(i)2.1, there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on in Schedule 2.1(s)(ii)2.1, there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the SecuritiesPreferred Shares, the Common Shares, the Warrant Shares or the Warrants.

Other Investors. Except as set forth on Schedule 2.1(s)(i2.1(t)(i), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule 2.1(s)(ii2.1(t)(ii), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would 7 8 be affected by the issuance of any of the SecuritiesDebentures, the Common Shares, the Warrants or the Warrant Shares.

Other Investors. Except as set forth on Schedule SCHEDULE 2.1(s)(i), there are no outstanding securities issued by the Company that are entitled to registration rights under the Act. Except as set forth on Schedule SCHEDULE 2.1(s)(ii), there are no outstanding securities issued by the Company that are directly or indirectly convertible into, exercisable into, or exchangeable for, shares of Common Stock of the Company, or that have anti-dilution or similar rights that would be affected by the issuance of any of the Securities.